Hot Features
Botanix Pharmaceuticals Limited operates as a commercial dermatology company in Australia and the United States. The company’s lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used on the skin to treat underarm sweating in adults and children 9 years of age a... Botanix Pharmaceuticals Limited operates as a commercial dermatology company in Australia and the United States. The company’s lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used on the skin to treat underarm sweating in adults and children 9 years of age and older. Its product pipeline includes BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX 1801 for treating staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 for the treatment of papulopustular rosacea; and BTX 1204A for treating atopic dermatitis. The company was incorporated in 1984 and is based in Melbourne, Australia. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.021 | 0.023 | 0.02 | 11493797 | 0.02158962 | DE |
| 4 | -0.008 | -27.5862068966 | 0.029 | 0.031 | 0.02 | 13421483 | 0.02440846 | DE |
| 12 | -0.027 | -56.25 | 0.048 | 0.049 | 0.02 | 23512229 | 0.03317101 | DE |
| 26 | -0.084 | -80 | 0.105 | 0.15 | 0.02 | 16150653 | 0.04780455 | DE |
| 52 | -0.319 | -93.8235294118 | 0.34 | 0.36 | 0.02 | 13303133 | 0.09691568 | DE |
| 156 | -0.079 | -79 | 0.1 | 0.535 | 0.02 | 8253739 | 0.20203037 | DE |
| 260 | -0.048 | -69.5652173913 | 0.069 | 0.535 | 0.02 | 5498483 | 0.18969739 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.